sur PharmaSGP Holding SE (isin : DE000A2P4LJ5)
PharmaSGP Holding SE Announces Delisting Offer by FUTRUE GmbH
PharmaSGP Holding SE has announced the commencement of the acceptance period for FUTRUE GmbH's public delisting tender offer. Shareholders have until August 11, 2025, to tender their shares in exchange for €28.00 per share. This move signifies a strategic step for the company as it considers transitioning away from public markets.
PharmaSGP specializes in over-the-counter pharmaceuticals focused on natural ingredients. The company has expanded its market presence across Europe, achieving significant revenue growth, reaching €118.8 million in 2024. This delisting forms part of FUTRUE GmbH's broader strategy to consolidate its holdings and streamline operations.
The tender offer and related documents can be accessed online, providing shareholders all necessary information. This development marks a pivotal moment for PharmaSGP, indicating potential realignment of its business focus.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de PharmaSGP Holding SE